ADHD and its medications may influence BMI in children and teens

Publicly released:
International
Photo by Christina Victoria Craft on Unsplash. Story by Rachel McDonald, Australian Science Media Centre
Photo by Christina Victoria Craft on Unsplash. Story by Rachel McDonald, Australian Science Media Centre

Prepubescent children and teens with attention deficit hyperactivity disorder (ADHD) - especially those taking medication - could be at risk of a higher BMI, according to international research. The team recruited nearly 13,000 children aged 6-11 and nearly 22,000 teens and compared their height and BMI over time, looking at whether they had an ADHD diagnosis and whether they were treating it with methylphenidate - sold as Concerta and Ritalin in Australia. Following this cohort into adulthood, the researchers say those with ADHD had on average a one point higher BMI compared to those without ADHD, and this link was stronger for those who had been on ADHD medication. There was no link between ADHD and shorter height but those taking the medication were on average slightly shorter, the researchers add. They say these findings don't mean ADHD medication shouldn't be given to young people to help them with their symptoms, but potential impacts on growth and weight should be considered.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: Korea University College of Medicine, South Korea, Seoul National University Hospital, South Korea
Funder: This study was supported by a grant from the Korea University and by grant RS-2025- 00523629 from the National Research Foundation of Korea funded by the Korean government.
Media Contact/s
Contact details are only visible to registered journalists.